The effect of percutaneous dilatation of renal arterial stenosis on captopril renography in hypertension

References

• Ives N. J., Wheatley K., Stowe R. L., Krijnen P., Plouin P. F., van Jaarsveld B. C., et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: A meta‐analysis of randomized trials. Nephrol Dial Transplant 2003; 18: 298–304
   PubMed Web of Science ®Google Scholar
• Ramos F., Kotliar C., Alvarez D., Baglivo H., Rafaelle P., Londero H., et al. Renal function and outcome of PTRA and stenting for atherosclerotic renal artery stenosis. Kidney Int 2003; 63: 276–282
   PubMed Web of Science ®Google Scholar
• Textor S. C. Ischemic nephropathy: Where are we now?. J Am Soc Nephrol 2004; 15: 1974–1982
   PubMed Web of Science ®Google Scholar
• Granerus G., Aurell M., Delin K., Karlberg B. E., Lorelius L. E. A Swedish view on the diagnosis of renovascular hypertension. J Intern Med 1992; 232: 15–24
   Google Scholar
• Granerus G., Moonen M. Effects of extra‐renal background subtraction and kidney depth correction in the measurement of GFR by gamma camera renography. Nucl Med Commun 1991; 12: 519–527
   PubMed Web of Science ®Google Scholar
• Taylor A., Nally J., Aurell M., Blaufox D., Dondi M., Dubovsky E., et al. Consensus report on ACE inhibitor renography for detecting renovascular hypertension. Radionuclides in Nephrourology Group. Consensus Group on ACEI Renography. J Nucl Med 1996; 37: 1876–1882
   PubMed Web of Science ®Google Scholar
• 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053
   PubMed Web of Science ®Google Scholar
• Hansen K. J., Edwards M. S., Craven T. E., Cherr G. S., Jackson S. A., Appel R. G., et al. Prevalence of renovascular disease in the elderly: A population‐based study. J Vasc Surg 2002; 36: 443–451
   PubMed Web of Science ®Google Scholar
• Plouin P. F. Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management. Am J Kidney Dis 2003; 42: 851–857
   Google Scholar
• Major outcomes in high‐risk hypertensive patients randomized to angiotensin‐converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981–2997
   PubMed Web of Science ®Google Scholar
• Rimmer J. M., Gennari F. J. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 1993; 118: 712–719
   PubMed Web of Science ®Google Scholar
• Caps M. T., Perissinotto C., Zierler R. E., Polissar N. L., Bergelin R. O., Tullis M. J., et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998; 98: 2866–2872
   PubMed Web of Science ®Google Scholar
• Webster J., Marshall F., Abdalla M., Dominiczak A., Edwards R., Isles C. G., et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998; 12: 329–335
   PubMed Web of Science ®Google Scholar
• Bakker J., Goffette P. P., Henry M., Mali W. P., Melki J. P., Moss J. G., et al. The Erasme study: A multicenter study on the safety and technical results of the Palmaz stent used for the treatment of atherosclerotic ostial renal artery stenosis. Cardiovasc Intervent Radiol 1999; 22: 468–474
   PubMedGoogle Scholar
• Morganti A., Bencini C., Del Vecchio C., Strata M. Treatment of atherosclerotic renal artery stenosis. J Am Soc Nephrol 2002; 13(Suppl 3)S187–S189
   PubMed Web of Science ®Google Scholar
• Taylor A. T, Jr., Fletcher J. W., Nally J. V, Jr., Blaufox M. D., Dubovsky E. V., Fine E. J., et al. Procedure guideline for diagnosis of renovascular hypertension. Society of Nuclear Medicine. J Nucl Med 1998; 39: 1297–1302
   PubMed Web of Science ®Google Scholar
• Muller‐Suur R., Tidgren B., Fehrm A., Lundberg H. J. Captopril‐induced changes in MAG3 clearance in patients with renal arterial stenosis and the effect of renal angioplasty. J Nucl Med 2000; 41: 1203–1208
   Google Scholar
• Nally J. V., Barton D. P. Contemporary approach to diagnosis and evaluation of renovascular hypertension. Urol Clin North Am 2001; 28: 781–791
   Google Scholar
• Malmqvist K., Ohman K. P., Lind L., Nystrom F., Kahan T. Relationships between left ventricular mass and the renin‐angiotensin system, catecholamines, insulin and leptin. J Intern Med 2002; 252: 430–439
   PubMed Web of Science ®Google Scholar
• Geddes C. C., Jardine A. G. Diagnosis and treatment of atherosclerotic renal artery stenosis (ARAS). Minerva Urol Nefrol 2002; 54: 29–36
   Google Scholar
• Marshall F. I., Hagen S., Mahaffy R. G., Petrie J. C., Roy‐Chaudhury P., Russell I. T., et al. Percutaneous transluminal angioplasty for atheromatous renal artery stenosis – blood pressure response and discriminant analysis of outcome predictors. Q J Med 1990; 75: 483–489
   Google Scholar
• van Jaarsveld B. C., Krijnen P., Pieterman H., Derkx F. H., Deinum J., Postma C. T., et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal‐artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000; 342: 1007–1014
   PubMed Web of Science ®Google Scholar
• Plouin P. F., Guery B., La Batide Alanore A. Atherosclerotic renal artery stenosis: Surgery, percutaneous transluminal angioplasty, or medical therapy?. Curr Hypertens Rep 2000; 2: 482–489
   Google Scholar
• Plouin P. F., Chatellier G., Darne B., Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998; 31: 823–829
   PubMed Web of Science ®Google Scholar